Introduction {#s0005}
============

Respiratory infections (e.g., fungi, bacteria, and coronavirus) can result in unknown intracranial infections and consequent neurological symptoms. For example, in the current COVID-19 epidemic in China, 78 (36.4%) of 214 patients with COVID-19 were admitted with neurological symptoms to Wuhan Union Hospital [@b0010], and we observed 2 cases of diabetes insipidus (DI) related to pituitary disorder in patients with severe COVID-19 (in the First Affiliated Hospital of Guangzhou Medical University). It is generally believed that pathogens cause intracranial infection by entering the subarachnoid space via nasopharyngeal or middle ear passages, blood flow, blood--brain, and cerebrospinal fluid (CSF) barriers, although we still cannot explain the existence of pathogens in the CSF, as the blood--brain barrier (BBB) can prevent the transmission of pathogens to the meninges [@b0005].

CSF originates from the choroid plexus of the intracranial lateral ventricle. The reflux of CSF to the lymphatic system plays an important role in cerebral immunity. CSF is drained through meningeal lymphatic vessels, which allow immune cells to enter draining lymph nodes (DLNs) and play an important role in cerebral immune defence. However, the [@b0030] exact underlying mechanisms of how immune cells from the peripheral [@b0015] lymphatic system enter the central nervous system (CNS) remain unknown [@b0025].

The perinasal lymphatic system is the first-line barrier of respiratory immunity against pathogen invasion of the respiratory tract and body. Respiratory infections can lead to CNS infections, but it is unclear whether the perinasal lymphatic system and lymphatic vessels are involved in cerebral immune defence and play a role in CNS infections caused by respiratory pathogens.

To elucidate the roles of the perinasal lymphatic system during cerebral infection (especially respiratory-related infections) and cerebral immune defence, we carried out an anatomic study to investigate the drainage differences between the perinasal and intracerebral lymphatic systems. Under an anatomic (20× magnification) microscope, we dissected the mouse intracranial nervous system after injection of Evans blue (perinasal lymphatic reflux assay) and found that lymphatic vessels that exist in the pituitary and loop the cerebral lymphatic circulation are responsible for the perinasal-pituitary lymphatic drainage.

Materials and methods {#s0010}
=====================

Antibodies and reagents {#s0015}
-----------------------

The Lyve1-Alexa 488 antibody was purchased from eBioscience (catalogue \# 53-0443-80) and used at a 1:250 dilution. Anti-CD31 was purchased from Abcam (catalogue \# ab222783) at a 1:100 dilution. Anti-rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody was purchased from Invitrogen Co., Ltd., (catalogue \# A32740) and used at a 1:1000 dilution. Evans blue and other reagents were purchased from Sangon Biotech (Shanghai) and were of high analytical grade.

Injection of Evans blue and anatomic surgery {#s0020}
============================================

Mice (BALB/c, 7 weeks old) were divided into different groups (5foreachgroup). For the treated groups, mice were anaesthetized with pentobarbital sodium (70 mg/kg) by intraperitoneal injections and then subcutaneously injected with 0.1 mL of Evans blue (5%) by microsyringe via either or both limbs, the tail and the perinasal area (e.g., bilateral the hindlimbs, the second toe of the dorsal feet, both flanks, the dorsal sides of the bilateral forelimbs, the bilateral retroauricular regions, the parietal midpoint between both ears, the tip of the nose, and the bilateral ventral mucosae of the tongue). The control groups received saline instead.

After injection, the mice were placed on a heating pad at a stable (25 °C) temperature for 4 h and then euthanized (350 mg/kg) for anatomic analysis. In brief, with the abdomen facing down, the dorsal fur of the mouse was moistened with saline, after which the dorsal skin was cut transversely and then longitudinally to the mouse nose to fully expose the skull with scissors. Then, the cervical muscles were cut off the skull from the foramen magnum to expose the brain. The brain was then removed with tweezers; nerves connecting the brain were also cut off to expose the pituitary for observation under a Zeiss operating microscope (Zeiss Opmi Primo ceiling-mount microscope, 20× magnification). Photos were taken with a Canon 5DSR camera (Micro Lens: Canon EF 100 mm f/2.8L IS USM; Micro Flash: Canon mr-14ex II).

Immunohistochemistry {#s0025}
====================

The pituitary was removed from the mouse, immersed in 4% PFA for fixation, and embedded in paraffin. The pituitary was transversely sectioned (Leica CM 1950) and adhered to a glass slide. The sections were then deparaffinized, after which they underwent antigen retrieval, 3% hydrogen peroxide solution blocking for endogenous peroxidase and 3% BSA blocking. The blocking buffer was discarded, and primary antibody in PBS was added to the section and incubated in a wet box at 4 °C overnight.

The glass slides were washed with PBS three times (5mineach) after incubation. Then, the slides were incubated with secondary antibody (HRP-labelled) for 50 min at room temperature. The sections then underwent DAB and Harris haematoxylin staining after three washes in PBS. Then, the section was mounted using neutral balsam, and the blue staining was reversed in ammonia water. Photos were taken under a fluorescence microscope (Leica DMI4000B).

Immunofluorescence assay {#s0030}
========================

The sections and slide preparation, antigen retrieval, BSA blocking, and primary and secondary antibody incubation processes were the same as the aforementioned conditions used for immunohistochemistry.

After staining with secondary antibodies, the glass slide was washed in PBS three times (5mineach). After the section dried slightly, DAPI was added to the sample, followed by 10 min of room temperature incubation in the dark. The glass slide was then washed again three times and mounted using an antifluorescence quenching mounting agent. Photos were taken under a confocal microscope (LSM710 laser confocal microscope, Zeiss).

Image processing {#s0035}
================

Adobe Photoshop, Fiji Image Analysis, and GraphPad Prism software were chosen for image processing.

Results {#s0040}
=======

Evans blue can directly reach the central region of the mouse pituitary after subcutaneous injection into the perinasal area {#s0045}
----------------------------------------------------------------------------------------------------------------------------

Two to four hours after the subcutaneous injection of Evans blue into the mouse limbs, tail, and perinasal area, we unexpectedly observed a light-blue, well-discriminated, regular "birds eye" region in the central pituitary [@b0040] ([Fig. 1](#f0005){ref-type="fig"} A; and B, [Fig. 1](#f0005){ref-type="fig"}C; see yellow arrow and circle; 5× magnification from 1A). Interestingly, the dye could not travel to the middle pituitary after injection in other parts of the body (limbs, tail) alone or injection of the perinasal area alone (data not shown). This result suggests that some kind of vessels and (drainage) tissues may exist in the central pituitary area and are extended from or connected with the perinasal tissue.Fig. 1Mouse pituitary anatomic and immunohistochemical analysis. A, Pituitary anatomic observation under a 20× magnification microscope after the subcutaneous injection of 50 μL of Evans blue at the perinasal region: a light-blue, well-discriminated, regular "birds eye" region was observed in the central pituitary. B, 5× magnification of the region selected with the microscope in A. C, Pituitary anatomic observation with the no-injection mice: the "birds eye" region was identifiable from peripheral white matter in the central pituitary (7× magnification). Photos were taken with a Canon 5DSR camera. D, Haematoxylin (HE) staining of pituitary tissue (D1-anterior pituitary/neurohypophysis; D2-posterior pituitary/adenohypophysis). E&F, Immunohistochemical staining of pituitary with the lymphatic endothelial marker Lyve-1 and HE staining (E-neurohypophysis, F-adenohypophysis; HE staining-blue, Lyve-1 staining-brown). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Lymphatic vasculatures may be enriched in the "birds eye" region in the central pituitary {#s0050}
=========================================================================================

We then dissected other untreated mice and found that the "birds eye" region exists in the central pituitary, which was identifiable but can be carefully discriminated from peripheral white matter ([Fig. 1](#f0005){ref-type="fig"}C; see green arrow and circle). We further performed pathological staining and confirmed that the "birds eye" region was actually the posterior pituitary or adenohypophysis ([Fig. 1](#f0005){ref-type="fig"}D). Moreover, lymphatic endothelial growth factor was found to be highly expressed in the "birds eye" region ([Fig. 1](#f0005){ref-type="fig"}E and F). These results suggest that lymphatic vasculature may be enriched in the adenohypophysis.

Lymphatic vasculature exists in the central pituitary region of the adenohypophysis. {#s0055}
====================================================================================

Thus, inspired by Louveau *et al*.'s study [@b0020], we conducted a further immunofluorescence assay to confirm the lymphatic vasculature in the central pituitary. As shown in [Fig. 2](#f0010){ref-type="fig"} , the central pituitary region of the adenohypophysis was positively labelled with the lymphatic endothelial marker Lyve-1 (green, [Fig. 2](#f0010){ref-type="fig"}B) as a capillary structure arrangement. Notably, no colocalization of the vascular endothelial cell markers CD31 (red in [Fig. 2](#f0010){ref-type="fig"}C) and Lyve-1 was found ([Fig. 2](#f0010){ref-type="fig"}D and [Fig. 3](#f0015){ref-type="fig"} ), suggesting that lymphatic vasculature but not blood vasculature exists in the central pituitary region of the adenohypophysis. We hypothesized that these small lymphatic vasculatures (called central pituitary lymphatic vessels) may maintain communication with the nasal lymphatic vessels.Fig. 2Lymphatic vasculatures existed and were enriched in the "birds eye" region of the central pituitary (adenohypophysis). A, Haematoxylin (HE) staining of pituitary tissue (scale bar: 100 μm). B, Immunofluorescence assay of pituitary tissue positively stained with the lymphatic endothelial marker Lyve-1 (green). C, Pituitary tissue that was positively stained with the vascular endothelial marker CD31 (red). D, Colocalization of vascular Lyve-1 and CD31. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3Capillary structures in the central pituitary (adenohypophysis) are likely lymphatic vessels and not blood vessels. A, Colocalization analysis of Lyve-1 and CD31 under the scope in [Fig. 2](#f0010){ref-type="fig"}D (upper right, the most colocalized area in [Fig. 2](#f0010){ref-type="fig"}D was selected and marked with a yellow line; scale bar: 100 μm). B, Immunofluorescence analysis showed no colocalization of Lyve-1 and CD31 (Fiji Image analysis). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Perinasal tissue may communicate with central pituitary lymphatic vessels in a specific and unidirectional manner {#s0060}
=================================================================================================================

Interestingly, in our study, Evans blue was concentrated in central pituitary lymphatic tissue only when it was injected around the perinasal tissue; Evans blue was not found in the pituitary when injected in other parts of the body (limbs or tail, data not shown). This finding may indicate that only perinasal lymphatic tissue (vessels) is specifically connected to the pituitary (central pituitary lymphatic tissue) in a unidirectional manner.

Discussion {#s0065}
==========

We acknowledge that the brain lacks classic lymph circulation according to our current understanding. However, it remains unclear how respiratory pathogens cause intracranial infection, how immune cells enter the brain for immune defence and whether the peripheral lymphatic system communicates with the central nervous system in addition to the meningeal lymphatic draining system.

In Louveau *et al*.'s cerebral lymphatic drainage study, Evans blue could not be detected in the deep cervical lymph nodes (dCLN) 30 min after injection into the nasal mucosa; therefore, the researchers believed that meningeal lymphatic vessels were the only way to drain CSF [@b0020]. However, our findings showed that Evans blue specifically accumulated in the middle of the adenohypophysis (possibly through the perinasal-pituitary lymphatic vessel pathway) 2 \~ 4 h after injection around the nasal mucosa. This finding suggests that Evans blue might be absorbed by the perinasal reticular (lymphatic) tissue and then reaches the pituitary via perinasal lymphatic drainage, through which it enters the CNS to participate in cerebral lymphatic circulation.

To the best of our knowledge, this is the first study that anatomically observed and showed the existence of lymphatic vessels in the pituitary (lymphatic drainage). Although further studies and evidence are needed to verify these results (from the lymphatic draining or from the immune defence perspective), we believe that this possible \"perinasal lymph-central pituitary lymph-central nervous system\" drainage route, together with classical \"meningeal lymphatic drainage\", can ultimately comprise a complete loop for the cerebral lymphatic circulation: the \"perinasal lymph-pituitary-CSF-meningeal lymph-perispinal lymph\" lymphatic drainage loop.

Taken together, our results, particularly those regarding the possible specificity and unidirectionality of the aforementioned perinasal-central pituitary lymphatic connection, indicate that pituitary-lymphatic drainage may play a key role in the regulation of cerebral infection caused by respiratory pathogens [@b0005], which invade the CNS via the perinasal tissue due to the abnormal communication of the \"perinasal-pituitary\" lymphatic refluxes [@b0005], [@b0035].
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